These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33792172)

  • 1. The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease.
    Lisman T; Hernandez-Gea V; Magnusson M; Roberts L; Stanworth S; Thachil J; Tripodi A
    J Thromb Haemost; 2021 Apr; 19(4):1116-1122. PubMed ID: 33792172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences.
    Lisman T; Porte RJ
    Blood; 2010 Aug; 116(6):878-85. PubMed ID: 20400681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to assess hemostasis in patients with severe liver disease.
    Lisman T
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):267-273. PubMed ID: 38066858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a rebalanced hemostatic system in pediatric liver transplantation: A prospective cohort study.
    Werner MJM; de Meijer VE; Adelmeijer J; de Kleine RHJ; Scheenstra R; Bontemps STH; Reyntjens KMEM; Hulscher JBF; Lisman T; Porte RJ
    Am J Transplant; 2020 May; 20(5):1384-1392. PubMed ID: 31841272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostasis testing in patients with liver dysfunction: Advantages and caveats.
    Nguyen G; Lejeune M; Crichi B; Frere C
    World J Gastroenterol; 2021 Nov; 27(42):7285-7298. PubMed ID: 34876789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viscoelastic tests in liver disease: where do we stand now?
    Buliarca A; Horhat A; Mocan T; Craciun R; Procopet B; Sparchez Z
    World J Gastroenterol; 2021 Jun; 27(23):3290-3302. PubMed ID: 34163112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bleeding in patients with liver disease.
    Northup PG; Lisman T; Roberts LN
    J Thromb Haemost; 2021 Jul; 19(7):1644-1652. PubMed ID: 33974330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostasis in liver disease: implications of new concepts for perioperative management.
    Weeder PD; Porte RJ; Lisman T
    Transfus Med Rev; 2014 Jul; 28(3):107-13. PubMed ID: 24721432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease.
    Driever EG; Lisman T
    Semin Thromb Hemost; 2022 Jul; 48(5):596-606. PubMed ID: 35135033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment.
    Lisman T; Leebeek FW
    Dig Surg; 2007; 24(4):250-8. PubMed ID: 17657149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary approach to the challenge of hemostasis.
    Levy JH; Dutton RP; Hemphill JC; Shander A; Cooper D; Paidas MJ; Kessler CM; Holcomb JB; Lawson JH;
    Anesth Analg; 2010 Feb; 110(2):354-64. PubMed ID: 20007735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver cirrhosis--procoagulant stasis].
    Prelipcean CC; Fierbinteanu-Braticevici C; Drug VL; Lăcătuşu C; Mihai B; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):678-85. PubMed ID: 22046771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemostatic alterations and management of haemostasis in patients with cirrhosis.
    Lisman T; Caldwell SH; Intagliata NM
    J Hepatol; 2022 Jun; 76(6):1291-1305. PubMed ID: 35589251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostasis and thrombosis in patients with liver disease: the ups and downs.
    Lisman T; Caldwell SH; Burroughs AK; Northup PG; Senzolo M; Stravitz RT; Tripodi A; Trotter JF; Valla DC; Porte RJ;
    J Hepatol; 2010 Aug; 53(2):362-71. PubMed ID: 20546962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coagulation disorders in liver cirrhosis - Diagnostics and management].
    Kasper P; Tacke F; Michels G
    Dtsch Med Wochenschr; 2024 Aug; 149(16):963-973. PubMed ID: 39094601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Disease and Hemostatic (Dys)function.
    Tripodi A
    Semin Thromb Hemost; 2015 Jul; 41(5):462-7. PubMed ID: 26080306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH.
    Roberts LN; Lisman T; Stanworth S; Hernandez-Gea V; Magnusson M; Tripodi A; Thachil J
    J Thromb Haemost; 2022 Jan; 20(1):39-47. PubMed ID: 34661370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and management of bleeding and thrombosis in patients with liver disease.
    van den Boom BP; Lisman T
    Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):79-88. PubMed ID: 35446468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostasis in patients with liver disease.
    van der Werf J; Porte RJ; Lisman T
    Acta Gastroenterol Belg; 2009; 72(4):433-40. PubMed ID: 20163038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebalanced Hemostasis in Patients with Acute Liver Failure.
    Lisman T; Stravitz RT
    Semin Thromb Hemost; 2015 Jul; 41(5):468-73. PubMed ID: 26049071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.